US Stock MarketDetailed Quotes
CLDI Calidi Biotherapeutics
- 2.140
- -0.010-0.47%
Close Nov 22 16:00 ET
- 2.101
- -0.039-1.83%
Post 20:01 ET
37.48MMarket Cap-713P/E (TTM)
2.200High1.960Low1.49MVolume2.120Open2.150Pre Close3.11MTurnover10.82%Turnover RatioLossP/E (Static)17.52MShares26.30052wk High-3.65P/B29.46MFloat Cap0.73052wk Low--Dividend TTM13.76MShs Float137.900Historical High--Div YieldTTM11.16%Amplitude0.730Historical Low2.091Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Calidi Biotherapeutics Stock Forum
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
Calidi Biotherapeutics presented data at IOVC and SITC conferences showcasing their RTNova™ systemic enveloped virotherapy technology for targeting metastatic lung cancer. The technology utilizes a tumor-selective vaccinia virus engineered to produce extracellular enveloped viruses (EEVs), designed to target multiple metastatic tumor sites while avo...
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
Calidi Biotherapeutics, Inc. (NYSE American: CLDI), a clinical-stage biotechnology company, has announced that NYSE Regulation staff has decided to initiate delisting proceedings for the company's warrants (ticker symbol CLDI WS) from the NYSE American. The warrants, each exercisable for 1/10th of a common stock share ...
📊⚡️📊
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
No comment yet